Ventrus Biosciences EV to Revenues (TTM)
View 4,000+ financial data types
Ventrus Biosciences EV to Revenues (TTM) Chart
Ventrus Biosciences Historical EV to Revenues (TTM) DataPro Export Data Date Range:
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / Revenues
Enterprise value of a company divided by its net revenues.
EV/Revenues answers the question "What is a company being valued per each dollar of revenues?" A high (low) EV/Revenues mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/EBITDA : How much is each dollar of EBITDA worth to investors?
EV/EBIT : Or each dollar of EBIT?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
VTUS EV to Revenues (TTM) Benchmarks
|Bell Rose Capital||Go Pro|
|Shandong Luoxin Pharmacy||Go Pro|
Street Insider 02/12 13:09 ET
Street Insider 02/12 11:11 ET
Street Insider 02/12 10:28 ET
Yahoo 02/12 08:07 ET
Street Insider 02/12 08:03 ET
Street Insider 02/12 07:58 ET
The Street 02/05 04:04 ET
Zacks 01/23 03:46 ET